{
  "content": "Diagnosis\n\t1. Gastric adenocarcinoma (mucinous type)\n\n\tDate of diagnosis\n\tJanuary 2024\n\n\tTreatment aim\n\tCurative\n\n\tSummary of completed treatment and relevant dates\n\n\tSurgery\n\t15 Feb 2024 Total gastrectomy with D2 lymphadenectomy\n\n\tChemotherapy\n\t1. Neo-adjuvant FLOT - 4 cycles completed December 2023 to January 2024\n\t2. Adjuvant FLOT - 4 cycles completed March to April 2024\n\n\tClinical studies\n\tNone\n\n\tCurrent disease status\n\tNo evidence of disease\n\n\tCurrent issues\n\tMild ongoing fatigue\n\n\tSummary of consultation\n\tI reviewed [redacted name] today following completion of adjuvant chemotherapy. He has completed all 8 cycles of perioperative FLOT chemotherapy as planned, with the final cycle given on 25/4/24. The treatment course has been relatively uncomplicated with only grade 1-2 toxicities including mild peripheral neuropathy and fatigue. His post-operative recovery has been excellent with good nutritional status maintained throughout adjuvant therapy.\n\nHe has adapted well to the post-gastrectomy dietary modifications and his weight has stabilized at 72kg (pre-treatment weight 78kg). Current ECOG performance status is 1. Blood tests today show stable parameters with hemoglobin 118 g/L, WCC 4.8, platelets 156, normal renal and liver function.\n\nOn examination today, his surgical wounds are well healed with no concerning features. He has no clinical evidence of disease recurrence.\n\n\tFurther investigations\n\tSurveillance CT chest/abdomen/pelvis booked for 3 months\n\n\tMedication prescribed\n\tVitamin B12 injections to continue every 3 months\n\n\tFollow up\n\tNext oncology follow up will be with CT results in 3 months\nSurgical follow up arranged with Mr [redacted name] in 6 weeks\n\n\tRequired GP actions\n\tPlease continue 3-monthly vitamin B12 injections\nMonitor iron studies and full blood count every 3 months\nRefer back urgently if any new concerning symptoms\n\n\tSummary of information given to the patient\n\tDiscussed completion of planned treatment course and transition to surveillance phase. Explained expected recovery timeline and importance of maintaining nutrition. Provided written information about post-treatment surveillance schedule and symptoms that should prompt early review.",
  "output": {
    "primary_cancer": {
      "site": "gastric",
      "year": 2024,
      "month": 1,
      "histopathology_status": "mucinous adenocarcinoma",
      "tnm_stage": "T3N2M0",
      "biomarker_status": "HER2 equivocal, MMR proficient",
      "cancer_timeline": [
        {
          "type": "treatment_systemic_start",
          "value": "Started neoadjuvant FLOT chemotherapy",
          "year": 2023,
          "month": 12
        },
        {
          "type": "treatment_surgery",
          "value": "Total gastrectomy with D2 lymphadenectomy",
          "year": 2024,
          "month": 2
        },
        {
          "type": "treatment_systemic_start",
          "value": "Started adjuvant FLOT chemotherapy",
          "year": 2024,
          "month": 3
        },
        {
          "type": "treatment_systemic_change",
          "value": "Completed planned course of 8 cycles of perioperative FLOT chemotherapy",
          "year": 2024,
          "month": 4
        }
      ]
    },
    "patient_facts": [
      {
        "type": "performance_status",
        "value": "ECOG PS 1"
      },
      {
        "type": "current_symptom",
        "value": "Mild fatigue"
      },
      {
        "type": "current_symptom",
        "value": "Mild peripheral neuropathy"
      },
      {
        "type": "investigation_finding",
        "value": "Hemoglobin 118 g/L, WCC 4.8, platelets 156, normal renal and liver function"
      },
      {
        "type": "examination_finding",
        "value": "Well healed surgical wounds, no clinical evidence of disease recurrence"
      },
      {
        "type": "quality_of_life_finding",
        "value": "Weight stable at 72kg, down from pre-treatment 78kg"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Gastric cancer treated with curative intent using perioperative FLOT chemotherapy and surgery. Successfully completed all planned treatment with good tolerance"
      },
      {
        "type": "latest_treatment_toxicity",
        "value": "Grade 1-2 toxicities including peripheral neuropathy and fatigue"
      },
      {
        "type": "update_to_treatment",
        "value": "Completed all planned treatment, transitioning to surveillance phase"
      },
      {
        "type": "planned_investigation",
        "value": "Surveillance CT chest/abdomen/pelvis in 3 months"
      },
      {
        "type": "follow_up_referral",
        "value": "Oncology review with CT results in 3 months, surgical follow up in 6 weeks"
      }
    ]
  }
}